Inhibition of isoprenylcysteine carboxylmethyltransferase sensitizes common chemotherapies in cervical cancer via Ras-dependent pathway

Isoprenylcysteine carboxylmethyltransferase (ICMT) catalyzes the last step of post-translational protein prenylation, which is essential for the stability and proper functions of many oncogenic proteins, such as Ras. Despite extensive studies on the roles of ICMT in tumor transformation and progression, little is known on the involvement ofIcmt in the development of tumor resistance to chemotherapy. Here we show the upregulation of ICMT as a persistent response to chemotherapy in cervical Cancer cells. In-depth functional analysis demonstrated that ICMT inhibition significantly inhibited growth, induced Apoptosis and augmented the inhibitory effects of chemotherapy drugs in cervical Cancer in Cell Culture system and xenograft mouse model. Importantly, combination of ICMT specific inhibitor cysmethynil with doxorubicin or paclitaxel at sublethal concentration achieved almost full inhibition of tumor cell growth and survival. The remarkable synergy between chemotherapy drugs and ICMT inhibition in cervical Cancer cells is likely due to the additional suppression of Ras and its downstream signaling pathways. We are the first to demonstrate the contribution of ICMT in tumor cells in response to chemotherapy. Our work also highlights ICMT inhibition as a sensitizing strategy for the treatment of cervical Cancer or other Ras-driven tumors.

Cervical cancer; Chemoresistance; Icmt; Ras.